» Articles » PMID: 20698736

Association Between Pregnancy Complications and Small-for-gestational-age Birth Weight Defined by Customized Fetal Growth Standard Versus a Population-based Standard

Overview
Publisher Informa Healthcare
Date 2010 Aug 12
PMID 20698736
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To derive coefficients for developing a customized growth chart for a Mid-Western US population, and to estimate the association between pregnancy outcomes and smallness for gestational age (SGA) defined by the customized growth chart compared with a population-based growth chart for the USA.

Method: A retrospective cohort study of an ultrasound database using 54,433 pregnancies meeting inclusion criteria was conducted. Coefficients for customized centiles were derived using 42,277 pregnancies and compared with those obtained from other populations. Two adverse outcome indicators were defined (greater than 7 day stay in the neonatal unit and stillbirth [SB]), and the risk for each outcome was calculated for the groups of pregnancies defined as SGA by the population standard and SGA by the customized standard using 12,456 pregnancies for the validation sample.

Results: The growth potential expressed as weight at 40 weeks in this population was 3524 g (standard error: 402 g). In the validation population, 4055 cases of SGA were identified using both population and customized standards. The cases additionally identified as SGA by the customized method had a significantly increased risk of each of the adverse outcome categories. The sensitivity and specificity of those identified as SGA by customized method only for detecting pregnancies at risk for SB was 32.7% (95% confidence interval [CI] 27.0-38.8%) and 95.1% (95% CI: 94.7-95.0%) versus 0.8% (95% CI 0.1-2.7%) and 98.0% (95% CI 97.8-98.2%)for those identified by only the population-based method, respectively.

Conclusion: SGA defined by customized growth potential is able to identify substantially more pregnancies at a risk for adverse outcome than the currently used national standard for fetal growth.

Citing Articles

The impact of HPV vaccination beyond cancer prevention: effect on pregnancy outcomes.

Yuill S, Velentzis L, Smith M, Egger S, Wrede C, Bateson D Hum Vaccin Immunother. 2021; 17(10):3562-3576.

PMID: 34506257 PMC: 8437490. DOI: 10.1080/21645515.2021.1936860.


Fetal growth prediction: Establishing fetal growth prediction curves in the second trimester.

Wang Y, Bao X, Zhang S, Yang L, Liu G, Yang Y Technol Health Care. 2021; 29(S1):345-350.

PMID: 33682771 PMC: 8150552. DOI: 10.3233/THC-218032.


Common maternal and fetal genetic variants show expected polygenic effects on risk of small- or large-for-gestational-age (SGA or LGA), except in the smallest 3% of babies.

Beaumont R, Kotecha S, Wood A, Knight B, Sebert S, McCarthy M PLoS Genet. 2020; 16(12):e1009191.

PMID: 33284794 PMC: 7721187. DOI: 10.1371/journal.pgen.1009191.


The Ghana PrenaBelt trial: a double-blind, sham-controlled, randomised clinical trial to evaluate the effect of maternal positional therapy during third-trimester sleep on birth weight.

Coleman J, Okere M, Seffah J, Kember A, OBrien L, Borazjani A BMJ Open. 2019; 9(4):e022981.

PMID: 31048420 PMC: 6502032. DOI: 10.1136/bmjopen-2018-022981.


Prediction of adverse perinatal outcome by fetal biometry: comparison of customized and population-based standards.

Kabiri D, Romero R, Gudicha D, Hernandez-Andrade E, Pacora P, Benshalom-Tirosh N Ultrasound Obstet Gynecol. 2019; 55(2):177-188.

PMID: 31006913 PMC: 6810752. DOI: 10.1002/uog.20299.